PDB Short entry for 1US0 HEADER OXIDOREDUCTASE 16-NOV-03 1US0 TITLE HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ AND THE INHIBITOR IDD594 TITLE 2 AT 0.66 ANGSTROM COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALDOSE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ALDEHYDE REDUCTASE; COMPND 5 EC: 1.1.1.21; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS OXIDOREDUCTASE, NADP, IDD594 EXPDTA X-RAY DIFFRACTION AUTHOR E.I.HOWARD,R.SANISHVILI,R.E.CACHAU,A.MITSCHLER,B.CHEVRIER,P.BARTH, AUTHOR 2 V.LAMOUR,M.VAN ZANDT,E.SIBLEY,C.BON,D.MORAS,T.R.SCHNEIDER, AUTHOR 3 A.JOACHIMIAK,A.PODJARNY REVDAT 5 22-MAY-19 1US0 1 REMARK REVDAT 4 05-MAR-14 1US0 1 JRNL REMARK VERSN DBREF REVDAT 4 2 1 SEQADV FORMUL ATOM REVDAT 3 24-FEB-09 1US0 1 VERSN REVDAT 2 10-MAR-05 1US0 1 HETNAM REVDAT 1 07-MAY-04 1US0 0 JRNL AUTH E.I.HOWARD,R.SANISHVILI,R.E.CACHAU,A.MITSCHLER,B.CHEVRIER, JRNL AUTH 2 P.BARTH,V.LAMOUR,M.VAN ZANDT,E.SIBLEY,C.BON,D.MORAS, JRNL AUTH 3 T.R.SCHNEIDER,A.JOACHIMIAK,A.PODJARNY JRNL TITL ULTRAHIGH RESOLUTION DRUG DESIGN I: DETAILS OF INTERACTIONS JRNL TITL 2 IN HUMAN ALDOSE REDUCTASE-INHIBITOR COMPLEX AT 0.66 A. JRNL REF PROTEINS V. 55 792 2004 JRNL REFN ISSN 0887-3585 JRNL PMID 15146478 JRNL DOI 10.1002/PROT.20015 REMARK 2 REMARK 2 RESOLUTION. 0.66 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.66 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 0.4 REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.094 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.094 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.103 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 25587 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 511265 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.084 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.084 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.093 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 21261 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 405150 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2492 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 98 REMARK 3 SOLVENT ATOMS : 613 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 3054.2 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 2445.2 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 199 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 33158 REMARK 3 NUMBER OF RESTRAINTS : 46316 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.016 REMARK 3 ANGLE DISTANCES (A) : 0.034 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.331 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.095 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.118 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.053 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.006 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.036 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.083 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: KRETSINGER REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1US0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-NOV-03. REMARK 100 THE DEPOSITION ID IS D_1290013967. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-APR-99 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.00 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.653 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 UTILIZING A SI-111 AND SAGITTAL REMARK 200 HORIZONTAL FOCUSING REMARK 200 OPTICS : 1.02-M FLAT MIRROR MADE OF REMARK 200 ZERODUR PROVIDING VERTICAL REMARK 200 FOCUSING AND REJECTION OF REMARK 200 HARMONIC CONTAMINATION REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ANL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 511265 REMARK 200 RESOLUTION RANGE HIGH (A) : 0.660 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.1 REMARK 200 DATA REDUNDANCY : 2.300 REMARK 200 R MERGE (I) : 0.02900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.66 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 0.68 REMARK 200 COMPLETENESS FOR SHELL (%) : 75.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.27900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELXL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AS DESCRIBED IN LAMOUR ET AL. (1999) REMARK 280 ACTA CRYSTALL. SECTION D 55:721-723, PH 5.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.29500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CATALYZES THE NADPH-DEPENDENT REDUCTION OF A WIDE RANGE OF REMARK 400 CARBONYL-CONTAINING COMPOUNDS INTO CORRESPONDING ALCOHOLS. REMARK 400 THE PROTEIN IS THOUGHT TO PLAY A KEY ROLE IN DIABETIC COMPLICATIONS REMARK 400 OF THREE OTHER TARGET TISSUES, NAMELY, NERVE, KIDNEY AND RETINA. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 314 REMARK 465 PHE A 315 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 312 ND1 CD2 CE1 NE2 REMARK 470 GLU A 313 CA C O CB CG CD OE1 REMARK 470 GLU A 313 OE2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 119 CE NZ REMARK 480 GLU A 126 CD OE1 OE2 REMARK 480 LYS A 221 CD CE NZ REMARK 480 GLU A 279 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 64 CD GLU A 64 OE1 1.522 REMARK 500 GLU A 64 CD GLU A 64 OE2 2.695 REMARK 500 GLU A 146 CG GLU A 146 CD 0.829 REMARK 500 GLU A 146 CD GLU A 146 OE2 -0.067 REMARK 500 GLU A 150 CD GLU A 150 OE2 -0.120 REMARK 500 HIS A 163 NE2 HIS A 163 CD2 -0.077 REMARK 500 GLU A 167 CD GLU A 167 OE1 -0.154 REMARK 500 GLU A 167 CD GLU A 167 OE2 0.113 REMARK 500 LYS A 194 CG LYS A 194 CD 1.294 REMARK 500 GLU A 223 CD GLU A 223 OE1 0.301 REMARK 500 GLU A 223 CD GLU A 223 OE2 0.280 REMARK 500 ASP A 277 CG ASP A 277 OD1 0.544 REMARK 500 ASP A 277 CG ASP A 277 OD2 0.601 REMARK 500 LYS A 307 CD LYS A 307 CE -0.390 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET A 0 CG - SD - CE ANGL. DEV. = 9.9 DEGREES REMARK 500 ARG A 3 NE - CZ - NH2 ANGL. DEV. = -6.4 DEGREES REMARK 500 GLU A 29 OE1 - CD - OE2 ANGL. DEV. = 11.2 DEGREES REMARK 500 GLU A 29 CG - CD - OE2 ANGL. DEV. = -13.1 DEGREES REMARK 500 ARG A 63 CD - NE - CZ ANGL. DEV. = 9.5 DEGREES REMARK 500 GLU A 64 OE1 - CD - OE2 ANGL. DEV. = -12.5 DEGREES REMARK 500 GLU A 64 CG - CD - OE2 ANGL. DEV. = 18.7 DEGREES REMARK 500 GLU A 120 OE1 - CD - OE2 ANGL. DEV. = -8.7 DEGREES REMARK 500 ASP A 134 CB - CG - OD2 ANGL. DEV. = -10.8 DEGREES REMARK 500 ASP A 134 CB - CG - OD2 ANGL. DEV. = -6.7 DEGREES REMARK 500 ASN A 136 O - C - N ANGL. DEV. = 9.8 DEGREES REMARK 500 ASP A 139 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 GLU A 146 CB - CG - CD ANGL. DEV. = -36.2 DEGREES REMARK 500 GLU A 146 CG - CD - OE1 ANGL. DEV. = -65.6 DEGREES REMARK 500 GLU A 146 CG - CD - OE2 ANGL. DEV. = 53.2 DEGREES REMARK 500 MET A 168 CA - CB - CG ANGL. DEV. = 13.4 DEGREES REMARK 500 CYS A 186 CA - CB - SG ANGL. DEV. = 6.7 DEGREES REMARK 500 GLU A 193 N - CA - CB ANGL. DEV. = -11.4 DEGREES REMARK 500 LYS A 194 CB - CG - CD ANGL. DEV. = -34.1 DEGREES REMARK 500 LYS A 194 CG - CD - CE ANGL. DEV. = 38.2 DEGREES REMARK 500 GLU A 223 OE1 - CD - OE2 ANGL. DEV. = 21.2 DEGREES REMARK 500 GLU A 223 CG - CD - OE2 ANGL. DEV. = -24.6 DEGREES REMARK 500 THR A 244 N - CA - CB ANGL. DEV. = 11.9 DEGREES REMARK 500 ASN A 272 N - CA - CB ANGL. DEV. = 11.1 DEGREES REMARK 500 PHE A 276 CB - CG - CD1 ANGL. DEV. = 7.8 DEGREES REMARK 500 ASP A 277 OD1 - CG - OD2 ANGL. DEV. = -50.7 DEGREES REMARK 500 ASP A 277 CB - CG - OD2 ANGL. DEV. = 24.8 DEGREES REMARK 500 SER A 282 N - CA - CB ANGL. DEV. = 9.1 DEGREES REMARK 500 ARG A 293 NE - CZ - NH2 ANGL. DEV. = -4.8 DEGREES REMARK 500 ARG A 296 NE - CZ - NH2 ANGL. DEV. = -4.3 DEGREES REMARK 500 LYS A 307 CG - CD - CE ANGL. DEV. = 32.0 DEGREES REMARK 500 LYS A 307 CD - CE - NZ ANGL. DEV. = 23.7 DEGREES REMARK 500 PHE A 311 CB - CG - CD2 ANGL. DEV. = -4.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 21 -3.60 82.16 REMARK 500 GLN A 65 35.35 70.22 REMARK 500 LYS A 85 -61.61 -26.74 REMARK 500 LEU A 190 81.73 -154.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE A 311 HIS A 312 148.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 GLU A 64 0.08 SIDE CHAIN REMARK 500 TYR A 209 0.07 SIDE CHAIN REMARK 500 ASP A 277 0.17 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2023 DISTANCE = 7.74 ANGSTROMS REMARK 525 HOH A2036 DISTANCE = 7.37 ANGSTROMS REMARK 525 HOH A2037 DISTANCE = 6.83 ANGSTROMS REMARK 525 HOH A2038 DISTANCE = 7.94 ANGSTROMS REMARK 525 HOH A2045 DISTANCE = 6.97 ANGSTROMS REMARK 525 HOH A2050 DISTANCE = 5.98 ANGSTROMS REMARK 525 HOH A2059 DISTANCE = 6.17 ANGSTROMS REMARK 525 HOH A2067 DISTANCE = 6.02 ANGSTROMS REMARK 525 HOH A2105 DISTANCE = 6.22 ANGSTROMS REMARK 525 HOH A2239 DISTANCE = 6.25 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP A 318 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LDT A 320 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT A 450 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ABN RELATED DB: PDB REMARK 900 ALDOSE REDUCTASE MUTANT WITH CYS 298 REPLACED BY SER (C298S) REMARK 900 COMPLEX WITH NADPH REMARK 900 RELATED ID: 1ADS RELATED DB: PDB REMARK 900 ALDOSE REDUCTASE COMPLEX WITH NADPH REMARK 900 RELATED ID: 1AZ1 RELATED DB: PDB REMARK 900 ALRESTATIN BOUND TO C298A/W219Y MUTANT HUMAN ALDOSE REDUCTASE REMARK 900 RELATED ID: 1AZ2 RELATED DB: PDB REMARK 900 CITRATE BOUND, C298A/W219Y MUTANT HUMAN ALDOSE REDUCTASE REMARK 900 RELATED ID: 1EF3 RELATED DB: PDB REMARK 900 FIDARESTAT BOUND TO HUMAN ALDOSE REDUCTASE REMARK 900 RELATED ID: 1EL3 RELATED DB: PDB REMARK 900 HUMAN ALDOSE REDUCTASE COMPLEXED WITH IDD384 INHIBITOR REMARK 900 RELATED ID: 1IEI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITHTHE REMARK 900 INHIBITOR ZENARESTAT. REMARK 900 RELATED ID: 1MAR RELATED DB: PDB REMARK 900 ALDOSE REDUCTASE REMARK 900 RELATED ID: 2ACQ RELATED DB: PDB REMARK 900 ALDOSE REDUCTASE WILD TYPE COMPLEXED WITH NADP+ AND GLUCOSE-6- REMARK 900 PHOSPHATE REMARK 900 RELATED ID: 2ACR RELATED DB: PDB REMARK 900 ALDOSE REDUCTASE WILD TYPE COMPLEXED WITH NADP+ AND CACODYLATE REMARK 900 RELATED ID: 2ACS RELATED DB: PDB REMARK 900 ALDOSE REDUCTASE WILD TYPE COMPLEXED WITH NADP+ AND CITRATE REMARK 900 RELATED ID: 2ACU RELATED DB: PDB REMARK 900 ALDOSE REDUCTASE MUTANT WITH TYR 48 REPLACED BY HIS (Y48H) REMARK 900 COMPLEXED WITH NADP+ AND CITRATE REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONFLICT ANNOTATED IN THE SEQADV CARDS BELOW HAS REMARK 999 HAS BEEN DESCRIBED IN J.BIOL.CHEM. 264:14775 (1989). REMARK 999 THE MEDLINE ID FOR THIS REFERENCE IS 89359274 AND THE REMARK 999 PUBMED ID FOR THE SAME IS 2504709. DBREF 1US0 A 0 315 UNP P15121 ALDR_HUMAN 1 316 SEQADV 1US0 ILE A 4 UNP P15121 LEU 5 SEE REMARK 999 SEQRES 1 A 316 MET ALA SER ARG ILE LEU LEU ASN ASN GLY ALA LYS MET SEQRES 2 A 316 PRO ILE LEU GLY LEU GLY THR TRP LYS SER PRO PRO GLY SEQRES 3 A 316 GLN VAL THR GLU ALA VAL LYS VAL ALA ILE ASP VAL GLY SEQRES 4 A 316 TYR ARG HIS ILE ASP CYS ALA HIS VAL TYR GLN ASN GLU SEQRES 5 A 316 ASN GLU VAL GLY VAL ALA ILE GLN GLU LYS LEU ARG GLU SEQRES 6 A 316 GLN VAL VAL LYS ARG GLU GLU LEU PHE ILE VAL SER LYS SEQRES 7 A 316 LEU TRP CYS THR TYR HIS GLU LYS GLY LEU VAL LYS GLY SEQRES 8 A 316 ALA CYS GLN LYS THR LEU SER ASP LEU LYS LEU ASP TYR SEQRES 9 A 316 LEU ASP LEU TYR LEU ILE HIS TRP PRO THR GLY PHE LYS SEQRES 10 A 316 PRO GLY LYS GLU PHE PHE PRO LEU ASP GLU SER GLY ASN SEQRES 11 A 316 VAL VAL PRO SER ASP THR ASN ILE LEU ASP THR TRP ALA SEQRES 12 A 316 ALA MET GLU GLU LEU VAL ASP GLU GLY LEU VAL LYS ALA SEQRES 13 A 316 ILE GLY ILE SER ASN PHE ASN HIS LEU GLN VAL GLU MET SEQRES 14 A 316 ILE LEU ASN LYS PRO GLY LEU LYS TYR LYS PRO ALA VAL SEQRES 15 A 316 ASN GLN ILE GLU CYS HIS PRO TYR LEU THR GLN GLU LYS SEQRES 16 A 316 LEU ILE GLN TYR CYS GLN SER LYS GLY ILE VAL VAL THR SEQRES 17 A 316 ALA TYR SER PRO LEU GLY SER PRO ASP ARG PRO TRP ALA SEQRES 18 A 316 LYS PRO GLU ASP PRO SER LEU LEU GLU ASP PRO ARG ILE SEQRES 19 A 316 LYS ALA ILE ALA ALA LYS HIS ASN LYS THR THR ALA GLN SEQRES 20 A 316 VAL LEU ILE ARG PHE PRO MET GLN ARG ASN LEU VAL VAL SEQRES 21 A 316 ILE PRO LYS SER VAL THR PRO GLU ARG ILE ALA GLU ASN SEQRES 22 A 316 PHE LYS VAL PHE ASP PHE GLU LEU SER SER GLN ASP MET SEQRES 23 A 316 THR THR LEU LEU SER TYR ASN ARG ASN TRP ARG VAL CYS SEQRES 24 A 316 ALA LEU LEU SER CYS THR SER HIS LYS ASP TYR PRO PHE SEQRES 25 A 316 HIS GLU GLU PHE HET NDP A 318 48 HET LDT A 320 24 HET CIT A 400 13 HET CIT A 450 13 HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 2 NDP PHOSPHATE HETNAM LDT IDD594 HETNAM CIT CITRIC ACID HETSYN LDT [2-(4-BROMO-2-FLUORO-BENZYLTHIOCARBAMOYL)-5-FLUORO- HETSYN 2 LDT PHENOXY]-ACETIC ACID FORMUL 2 NDP C21 H30 N7 O17 P3 FORMUL 3 LDT C16 H12 BR F2 N O3 S FORMUL 4 CIT 2(C6 H8 O7) FORMUL 6 HOH *613(H2 O) HELIX 1 1 PRO A 23 GLY A 38 1 16 HELIX 2 2 ALA A 45 GLN A 49 5 5 HELIX 3 3 ASN A 50 GLU A 64 1 15 HELIX 4 4 LYS A 68 LEU A 72 5 5 HELIX 5 5 TRP A 79 HIS A 83 5 5 HELIX 6 6 LEU A 87 LYS A 100 1 14 HELIX 7 7 ASN A 136 GLU A 150 1 15 HELIX 8 8 ASN A 162 ASN A 171 1 10 HELIX 9 9 GLN A 192 LYS A 202 1 11 HELIX 10 10 ASP A 230 ASN A 241 1 12 HELIX 11 11 THR A 243 ARG A 255 1 13 HELIX 12 12 THR A 265 LYS A 274 1 10 HELIX 13 13 SER A 281 SER A 290 1 10 HELIX 14 14 LEU A 300 THR A 304 5 5 SHEET 1 AA 2 ARG A 3 LEU A 5 0 SHEET 2 AA 2 LYS A 11 PRO A 13 -1 O MET A 12 N ILE A 4 SHEET 1 AB 8 LEU A 17 GLY A 18 0 SHEET 2 AB 8 HIS A 41 ASP A 43 1 O HIS A 41 N LEU A 17 SHEET 3 AB 8 PHE A 73 LEU A 78 1 O PHE A 73 N ILE A 42 SHEET 4 AB 8 LEU A 106 ILE A 109 1 O LEU A 106 N SER A 76 SHEET 5 AB 8 ILE A 156 SER A 159 1 O GLY A 157 N ILE A 109 SHEET 6 AB 8 VAL A 181 GLU A 185 1 O VAL A 181 N ILE A 158 SHEET 7 AB 8 VAL A 205 TYR A 209 1 O VAL A 205 N ASN A 182 SHEET 8 AB 8 VAL A 258 VAL A 259 1 O VAL A 258 N ALA A 208 SITE 1 AC1 40 GLY A 18 THR A 19 TRP A 20 LYS A 21 SITE 2 AC1 40 ASP A 43 TYR A 48 LYS A 77 HIS A 110 SITE 3 AC1 40 TRP A 111 SER A 159 ASN A 160 GLN A 183 SITE 4 AC1 40 TYR A 209 SER A 210 PRO A 211 LEU A 212 SITE 5 AC1 40 GLY A 213 SER A 214 PRO A 215 ASP A 216 SITE 6 AC1 40 ALA A 245 ILE A 260 PRO A 261 LYS A 262 SITE 7 AC1 40 SER A 263 VAL A 264 THR A 265 ARG A 268 SITE 8 AC1 40 GLU A 271 ASN A 272 LDT A 320 HOH A2491 SITE 9 AC1 40 HOH A2494 HOH A2590 HOH A2591 HOH A2592 SITE 10 AC1 40 HOH A2593 HOH A2594 HOH A2595 HOH A2596 SITE 1 AC2 10 TRP A 20 VAL A 47 TYR A 48 HIS A 110 SITE 2 AC2 10 TRP A 111 THR A 113 CYS A 298 ALA A 299 SITE 3 AC2 10 LEU A 300 NDP A 318 SITE 1 AC3 13 ASN A 162 HIS A 163 LYS A 194 LEU A 195 SITE 2 AC3 13 HOH A2374 HOH A2375 HOH A2597 HOH A2598 SITE 3 AC3 13 HOH A2599 HOH A2600 HOH A2601 HOH A2602 SITE 4 AC3 13 HOH A2603 SITE 1 AC4 16 GLN A 49 ASN A 50 GLU A 51 ASN A 52 SITE 2 AC4 16 GLU A 53 LYS A 94 ASP A 98 HOH A2604 SITE 3 AC4 16 HOH A2605 HOH A2606 HOH A2607 HOH A2608 SITE 4 AC4 16 HOH A2609 HOH A2610 HOH A2611 HOH A2612 CRYST1 49.280 66.590 47.260 90.00 92.40 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020292 0.000000 0.000850 0.00000 SCALE2 0.000000 0.015017 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021178 0.00000